These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6768043)

  • 1. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M; Szendei G; Kovács I; Somos P
    Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia in polycystic ovary syndrome.
    Luciano AA; Chapler FK; Sherman BM
    Fertil Steril; 1984 May; 41(5):719-25. PubMed ID: 6425087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.
    Corenblum B; Taylor PJ
    Fertil Steril; 1982 Nov; 38(5):549-52. PubMed ID: 6813147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
    Wortsman J; Hirschowitz JS
    Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
    Shoupe D; Lobo RA
    Fertil Steril; 1985 Apr; 43(4):549-53. PubMed ID: 3921411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.
    Carmina E; Rosato F; Maggiore M; Gagliano AM; Indovina D; Jannì A
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):99-104. PubMed ID: 6229966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
    Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
    Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a dopaminergic drug on LH, FSH and prolactin levels in PCO syndrome.
    Venturini PL; Alibrandi MP; Costantini S; Gaggero G; Penna L; Valenzano M; Ragni N
    Acta Eur Fertil; 1981 Sep; 12(3):295-7. PubMed ID: 6803505
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
    Falaschi P; Rocco A; del Pozo E
    J Clin Endocrinol Metab; 1986 Feb; 62(2):348-51. PubMed ID: 3510225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation.
    Barnes RB; Lobo RA
    J Clin Endocrinol Metab; 1985 Oct; 61(4):779-82. PubMed ID: 3928677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinaemia in polycystic ovary syndrome.
    Lunde O
    Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary amenorrhoea associated with polycystic ovarian syndrome.
    Valkov IM; Dokumov SI
    Reproduccion; 1981; 5(2):119-26. PubMed ID: 6790313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin release in polycystic ovarian syndrome.
    Minakami H; Abe N; Oka N; Kimura K; Tamura T; Tamada T
    Endocrinol Jpn; 1988 Apr; 35(2):303-10. PubMed ID: 3145187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid peptides in pseudocyesis.
    Devane GW; Vera MI; Buhi WC; Kalra PS
    Obstet Gynecol; 1985 Feb; 65(2):183-8. PubMed ID: 3918282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.